PVLA
Palvella Therapeutics (PVLA)
$29
About Palvella Therapeutics (PVLA)
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
Details
Daily high
$121.72
Daily low
$113.61
Price at open
$113.61
52 Week High
$151.18
52 Week Low
$20.20
Market cap
1.7B
Dividend yield
0.00%
Volume
231,545
Avg. volume
215,005
P/E ratio
-29.09
Palvella Therapeutics News
Details
Daily high
$121.72
Daily low
$113.61
Price at open
$113.61
52 Week High
$151.18
52 Week Low
$20.20
Market cap
1.7B
Dividend yield
0.00%
Volume
231,545
Avg. volume
215,005
P/E ratio
-29.09